These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3045504)

  • 21. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens.
    Bonadio M; Maccanti O; Cosci S; Giordani R
    J Chemother; 1989 Jul; 1(4 Suppl):58-60. PubMed ID: 16312303
    [No Abstract]   [Full Text] [Related]  

  • 22. [New aspects on resistance to beta-lactam antibiotics].
    Bakken JS; Sanders CC
    Nord Med; 1987; 102(12):354-6. PubMed ID: 3697059
    [No Abstract]   [Full Text] [Related]  

  • 23. The postantibiotic effect (PAE) of the new penem FCE 22101 on gram-positive and -negative bacteria in vitro and in vivo.
    Bergholm AM; Dornbusch K
    J Chemother; 1989 Jul; 1(4 Suppl):64-6. PubMed ID: 16312306
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibacterial activity of mezlocillin against gram-negative and gram-positive bacteria from clinical isolates].
    Ravizzola G; Foresti I; Minelli F
    G Ital Chemioter; 1985; 32(2):277-80. PubMed ID: 3833562
    [No Abstract]   [Full Text] [Related]  

  • 25. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA; Rossolini GM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
    [No Abstract]   [Full Text] [Related]  

  • 26. The susceptibility of certain bacterial strains to imidazotriazine derivatives.
    Sztanke K; Sidor-Wójtowicz A; Truchlińska J; Pasternak K; Sztanke M
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):96-9. PubMed ID: 16146057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azthreonam: in vitro activity.
    Gobernado M; Cantón E; Santos M
    Microbiol Esp; 1983; 36(3-4):123-32. PubMed ID: 6687197
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lytic action of lysoamidase from Xanthomonas sp. correlates with the presence of the target ribitol teichoic acids in the cell wall of gram-positive bacteria].
    Kulaev IS; Naumova IB; Streshinskaia GM; Tul'skaia EM; Stepnaia OA; Severin AI; Begunova EA
    Mikrobiologiia; 1996; 65(3):326-32. PubMed ID: 8992241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different modes of action of naphthyridones in gram-positive and gram-negative bacteria.
    Buurman ET; Johnson KD; Kelly RK; MacCormack K
    Antimicrob Agents Chemother; 2006 Jan; 50(1):385-7. PubMed ID: 16377719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization of thermophilic strain SY-14 with capability to lyse bacterial cells].
    Song YD; Hu HY; Xi JY
    Huan Jing Ke Xue; 2007 Sep; 28(9):2106-11. PubMed ID: 17990566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of Inula helenium L. essential oil against Gram-positive and Gram-negative bacteria and Candida spp.
    Deriu A; Zanetti S; Sechi LA; Marongiu B; Piras A; Porcedda S; Tuveri E
    Int J Antimicrob Agents; 2008 Jun; 31(6):588-90. PubMed ID: 18450429
    [No Abstract]   [Full Text] [Related]  

  • 36. Bacteriological study of neonatal septicaemia cases and their in vitro sensitivity to antimicrobial agents.
    Chandna A; Chahar CK; Khatri PC; Miglani N
    J Postgrad Med; 1984 Jul; 30(3):167-70. PubMed ID: 6481652
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART.
    Shahum A; Benca G; Duong LS; Augustin A; Havlik S; Liska A; Kalavsky E; Beno P; Krcmery V
    J Antimicrob Chemother; 2007 Jul; 60(1):194-7. PubMed ID: 17545143
    [No Abstract]   [Full Text] [Related]  

  • 38. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
    Ravizzola G; Bonfanti C; Savoldi E; Turano A
    Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sensitivity of bacteria to antibiotics (Zurich, 2000)].
    Zbinden R; Pfyffer GE; Wüst J
    Praxis (Bern 1994); 2001 Dec; 90(50):2205-16. PubMed ID: 11793839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.